The Oncosearch | Oncotarget

Identification of novel, in vivo active Chk1 inhibitors utilizing structure guided drug design Research Paper

Andrew J. Massey, Stephen Stokes, Helen Browne, Nicolas Foloppe, AndreÃ¡ Fiumana, Simon Scrace, Mandy Fallowfield, Simon Bedford, Paul Webb, Lisa Baker, Mark Christie, Martin J. Drysdale, Mike Wood

Published Sep 30, 2015 · Vol. 6, No. 34 · pp. 35797-35812

c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations Research Paper

Anna Otte, Finn Rauprich, Juliane von der Ohe, Yuanyuan Yang, Friedrich Kommoss, Friedrich Feuerhake, Peter Hillemanns, Ralf Hass

Published Sep 30, 2015 · Vol. 6, No. 31 · pp. 31640-31658

Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2 Research Paper

Atanasio Pandiella, Francisco MorÃs, Alberto OcaÃ±a, Luz-Elena NÃºÃ±ez, Juan C. Montero

Published Sep 30, 2015 · Vol. 6, No. 32 · pp. 32856-32867

Caspase 3 in dying tumor cells mediates post-irradiation angiogenesis Priority Research Paper

Xiao Feng, Ling Tian, Zhengxiang Zhang, Yang Yu, Jin Cheng, Yanping Gong, Chuan-Yuan Li, Qian Huang

Published Sep 29, 2015 · Vol. 6, No. 32 · pp. 32353-32367

Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer Research Paper

Manish R. Patel, Blake A. Jacobson, Yan Ji, Jeremy Drees, Shaogeng Tang, Kerry Xiong, Hengbing Wang, Jennifer E. Prigge, Alexander S. Dash, Andrea K. Kratzke, Emily Mesev, Ryan Etchison, Mark J. Federspiel, Stephen J. Russell, Robert A. Kratzke

Published Sep 28, 2015 · Vol. 6, No. 32 · pp. 33165-33177

Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancer Research Paper

Fan Zeng, Rui-Jun Ju, Lei Liu, Hong-Jun Xie, Li-Min Mu, Yao Zhao, Yan Yan, Ying-Jie Hu, Jia-Shuan Wu, Wan-Liang Lu

Published Sep 28, 2015 · Vol. 6, No. 34 · pp. 36625-36642

Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis Research Paper

Da Eun Jeong, Hye Jin Song, Sharon Lim, Se Jeong Lee, Joung Eun Lim, Do-Hyun Nam, Kyeung Min Joo, Byong Chang Jeong, Seong Soo Jeon, Han Yong Choi, Hye Won Lee

Published Sep 28, 2015 · Vol. 6, No. 32 · pp. 33046-33064

Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo Research Paper

Zhiyun Yu, Gang Zhao, Guifang Xie, Liyan Zhao, Yong Chen, Hongquan Yu, Zhonghua Zhang, Cai Li, Yunqian Li

Published Sep 26, 2015 · Vol. 6, No. 32 · pp. 32930-32943

Inhibition of testicular embryonal carcinoma cell tumorigenicity by peroxisome proliferator-activated receptor-Î²/Î´- and retinoic acid receptor-dependent mechanisms Research Paper

Pei-Li Yao, Li Ping Chen, Tomasz P. DobrzaÅ„ski, Dylan A. Phillips, Bokai Zhu, Boo-Hyon Kang, Frank J. Gonzalez, Jeffrey M. Peters

Published Sep 26, 2015 · Vol. 6, No. 34 · pp. 36319-36337

RhoGDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression Research Paper

William P. Bozza, Yaqin Zhang, Kory Hallett, Leslie A. Rivera Rosado, Baolin Zhang

Published Sep 25, 2015 · Vol. 6, No. 32 · pp. 32723-32736

Application of a patient-derived xenograft model in cytolytic viral activation therapy for nasopharyngeal carcinoma Research Paper

Cheng-Lung Hsu, Yung-Chia Kuo, Yenlin Huang, Yin-Cheng Huang, Kar-Wai Lui, Kai-Ping Chang, Tung-Liang Lin, Hsien-Chi Fan, An-Chi Lin, Chia-Hsun Hsieh, Li-Yu Lee, Hung-Ming Wang, Hsin-Pai Li, Yu-Sun Chang

Published Sep 24, 2015 · Vol. 6, No. 31 · pp. 31323-31334

Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer Research Paper

Ji-Young Ahn, Ji-Sun Lee, Hye-Young Min, Ho-Young Lee

Published Sep 23, 2015 · Vol. 6, No. 32 · pp. 32622-32633

Visualizing the antivascular effect of bortezomib on the hypoxic tumor microenvironment Research Paper

Xiaorong Sun, Ellen Ackerstaff, Fuqiu He, Ligang Xing, Hung Tsung Hsiao, Jason A. Koutcher, C. Clifton Ling, Gloria C. Li

Published Sep 23, 2015 · Vol. 6, No. 33 · pp. 34732-34744

A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer Research Paper

Edward J. Richards, Jennifer Permuth-Wey, Yajuan Li, Y. Ann Chen, Domenico Coppola, Brett M. Reid, Hui-Yi Lin, Jamie K. Teer, Andrew Berchuck, Michael J. Birrer, Kate Lawrenson, Alvaro N.A. Monteiro, Joellen M. Schildkraut, Ellen L. Goode, Simon A. Gayther, Thomas A. Sellers, Jin Q. Cheng

Published Sep 22, 2015 · Vol. 6, No. 33 · pp. 34745-34757

TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling Research Paper

Xiquan Ke, Yan Zhao, Xinlan Lu, Zhe Wang, Yuanyuan Liu, Mudan Ren, Guifang Lu, Dan Zhang, Zhenguo Sun, Zhipeng Xu, Jee Hoon Song, Yulan Cheng, Stephen J. Meltzer, Shuixiang He

Published Sep 21, 2015 · Vol. 6, No. 32 · pp. 32610-32621

Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression Research Paper

Mingsong Wu, Shuhui Si, Yan Li, Susan Schoen, Guang-Qian Xiao, Xueying Li, Bin Tean Teh, Guan Wu, Jindong Chen

Published Sep 21, 2015 · Vol. 6, No. 32 · pp. 32761-32773

HER2 as a novel therapeutic target for cervical cancer Research Paper

Doo-Yi Oh, Seokhwi Kim, Yoon-La Choi, Young Jae Cho, Ensel Oh, Jung-Joo Choi, Kyungsoo Jung, Ji-Young Song, Suzie E. Ahn, Byoung-Gie Kim, Duk-Soo Bae, Woong-Yang Park, Jeong-Won Lee, Sangyong Song

Published Sep 21, 2015 · Vol. 6, No. 34 · pp. 36219-36230

BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas Research Paper

Meng Dai, Jian-Jun Lu, Wei Guo, Wendan Yu, Qimin Wang, Ranran Tang, Zhipeng Tang, Yao Xiao, Zhenglin Li, Wei Sun, Xiuna Sun, Yu Qin, Wenlin Huang, Wuguo Deng, Taihua Wu

Published Sep 21, 2015 · Vol. 6, No. 32 · pp. 33878-33892

FXR induces SOCS3 and suppresses hepatocellular carcinoma Research Paper

Fei Guo, Zhizhen Xu, Yan Zhang, Peng Jiang, Gang Huang, Shan Chen, Xilin Lyu, Ping Zheng, Xin Zhao, Yijun Zeng, Shuguang Wang, Fengtian He

Published Sep 21, 2015 · Vol. 6, No. 33 · pp. 34606-34616

Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery Research Paper

Chiara Romani, Emiliano Cocco, Eliana Bignotti, Daniele Moratto, Antonella Bugatti, Paola Todeschini, Elisabetta Bandiera, Renata Tassi, Laura Zanotti, Sergio Pecorelli, Enrico Sartori, Franco E. Odicino, Ario de Marco, Alessandro Davide Santin, Antonella Ravaggi, Stefania Mitola

Published Sep 21, 2015 · Vol. 6, No. 33 · pp. 34617-34628

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Identification of novel, in vivo active Chk1 inhibitors utilizing structure guided drug design Research Paper

c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations Research Paper

Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2 Research Paper

Caspase 3 in dying tumor cells mediates post-irradiation angiogenesis Priority Research Paper

Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer Research Paper

Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancer Research Paper

Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis Research Paper

Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo Research Paper

Inhibition of testicular embryonal carcinoma cell tumorigenicity by peroxisome proliferator-activated receptor-Î²/Î´- and retinoic acid receptor-dependent mechanisms Research Paper

RhoGDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression Research Paper

Application of a patient-derived xenograft model in cytolytic viral activation therapy for nasopharyngeal carcinoma Research Paper

Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer Research Paper

Visualizing the antivascular effect of bortezomib on the hypoxic tumor microenvironment Research Paper

A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer Research Paper

TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling Research Paper

Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression Research Paper

HER2 as a novel therapeutic target for cervical cancer Research Paper

BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas Research Paper

FXR induces SOCS3 and suppresses hepatocellular carcinoma Research Paper

Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Identification of novel, in vivo active Chk1 inhibitors utilizing structure guided drug design Research Paper

c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations Research Paper

Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2 Research Paper

Caspase 3 in dying tumor cells mediates post-irradiation angiogenesis Priority Research Paper

Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer Research Paper

Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancer Research Paper

Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis Research Paper

Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo Research Paper

Inhibition of testicular embryonal carcinoma cell tumorigenicity by peroxisome proliferator-activated receptor-Î²/Î´- and retinoic acid receptor-dependent mechanisms Research Paper

RhoGDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression Research Paper

Application of a patient-derived xenograft model in cytolytic viral activation therapy for nasopharyngeal carcinoma Research Paper

Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer Research Paper

Visualizing the antivascular effect of bortezomib on the hypoxic tumor microenvironment Research Paper

A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer Research Paper

TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling Research Paper

Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression Research Paper

HER2 as a novel therapeutic target for cervical cancer Research Paper

BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas Research Paper

FXR induces SOCS3 and suppresses hepatocellular carcinoma Research Paper

Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery Research Paper